ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-02092
製品名称
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His)
タンパク質名
CLEC12A/MICL/CLL-1
Species
Human
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms HECL, CLL-1, CD303, PRO34150, DCAL-2, CLL1, DLEC, CLECSF11, CLECSF7, C-type lectin domain family 12, member A, CD371, MICL
Characteristics Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity SDS-PAGE: 99.3%; SEC-HPLC: 99.1%
Description CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 41~45 kDa and the accession number is EAW96132.1.
Reference Marshall AS,et al.(2006) Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur J Immunol. 36(8): 2159-69.,Lahoud MH,et al.(2009) The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol. 182(12): 7587-94.,Pyz E,et al.(2008) Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. Eur J Immunol. 38(4): 1157-63.
URL https://www.targetmol.com/recombinant-protein/clec12a_protein_human_recombinant_ecd_his_tag_hplc_verified

お問い合わせリスト(-)

お問い合わせフォーム